Toshiaki Nakano

4.1k total citations
203 papers, 2.5k citations indexed

About

Toshiaki Nakano is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Toshiaki Nakano has authored 203 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Nephrology, 41 papers in Surgery and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Toshiaki Nakano's work include Dialysis and Renal Disease Management (59 papers), Parathyroid Disorders and Treatments (29 papers) and Chronic Kidney Disease and Diabetes (28 papers). Toshiaki Nakano is often cited by papers focused on Dialysis and Renal Disease Management (59 papers), Parathyroid Disorders and Treatments (29 papers) and Chronic Kidney Disease and Diabetes (28 papers). Toshiaki Nakano collaborates with scholars based in Japan, United States and Russia. Toshiaki Nakano's co-authors include Takanari Kitazono, Kazuhiko Tsuruya, Shunsuke Yamada, Katsuo Sueishi, Masatomo Taniguchi, Masanori Tokumoto, Yoshikazu Yonemitsu, Shigeru Tanaka, Toshiharu Ninomiya and Mitsuo Iida and has published in prestigious journals such as Nature Genetics, PLoS ONE and Cancer Research.

In The Last Decade

Toshiaki Nakano

178 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshiaki Nakano Japan 25 858 613 482 373 328 203 2.5k
Miho Shimizu Japan 26 1.2k 1.4× 571 0.9× 281 0.6× 278 0.7× 332 1.0× 121 2.7k
In Joo Kim South Korea 26 515 0.6× 479 0.8× 474 1.0× 279 0.7× 316 1.0× 136 2.6k
A. Testa Italy 26 609 0.7× 330 0.5× 372 0.8× 213 0.6× 427 1.3× 86 2.1k
Yusuf Oğuz Türkiye 30 952 1.1× 288 0.5× 421 0.9× 249 0.7× 303 0.9× 54 2.4k
Hui Huang China 28 344 0.4× 870 1.4× 340 0.7× 316 0.8× 274 0.8× 187 2.7k
Jacob van den Born Netherlands 36 1.1k 1.3× 888 1.4× 553 1.1× 260 0.7× 277 0.8× 119 3.3k
Waichi Sato Japan 30 994 1.2× 988 1.6× 336 0.7× 211 0.6× 330 1.0× 79 2.9k
Hyunjin Noh South Korea 32 976 1.1× 1.1k 1.8× 577 1.2× 121 0.3× 298 0.9× 104 3.0k
Takeshi F. Andoh United States 32 760 0.9× 794 1.3× 939 1.9× 270 0.7× 494 1.5× 69 3.7k
Rui Zeng China 27 712 0.8× 753 1.2× 343 0.7× 361 1.0× 436 1.3× 100 2.5k

Countries citing papers authored by Toshiaki Nakano

Since Specialization
Citations

This map shows the geographic impact of Toshiaki Nakano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Nakano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Nakano more than expected).

Fields of papers citing papers by Toshiaki Nakano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiaki Nakano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Nakano. The network helps show where Toshiaki Nakano may publish in the future.

Co-authorship network of co-authors of Toshiaki Nakano

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Nakano. A scholar is included among the top collaborators of Toshiaki Nakano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Nakano. Toshiaki Nakano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sasaki, Sho, Kiichiro Fujisaki, Masato Nishimura, et al.. (2025). QT-Interval Prolongation and 1-Year Cardiac Death Among Patients Undergoing Hemodialysis. JACC Asia. 5(1). 122–124.
2.
Tanaka, Shigeru, et al.. (2024). Estimated potassium intake and the progression of chronic kidney disease. Nephrology Dialysis Transplantation. 40(7). 1362–1373. 3 indexed citations
3.
Matsukuma, Yuta, et al.. (2024). Managing malignant hypertension with renal TMA: a case for caution in blood-pressure reduction. CEN Case Reports. 14(2). 271–279.
4.
Nakahara, Takako, Hajime Nagasu, Seiji Kishi, et al.. (2024). Association between proteinuria and mineral metabolism disorders in chronic kidney disease: the Japan chronic kidney disease database extension (J-CKD-DB-Ex). Scientific Reports. 14(1). 27481–27481. 1 indexed citations
5.
6.
7.
Torisu, Takehiro, Keisuke Kawasaki, Akihiro Tsuchimoto, et al.. (2023). Clinical Features of Gastroduodenal Ulcers in Kidney Transplant Patients. Internal Medicine. 62(23). 3437–3443.
8.
Maehara, Takashi, Ryusuke Munemura, Atsushi Doi, et al.. (2023). Granzyme K– and amphiregulin-expressing cytotoxic T cells and activated extrafollicular B cells are potential drivers of IgG4-related disease. Journal of Allergy and Clinical Immunology. 153(4). 1095–1112. 15 indexed citations
9.
Sugawara, Yuka, Yosuke Hirakawa, Hajime Nagasu, et al.. (2022). Genome-wide association study of the risk of chronic kidney disease and kidney-related traits in the Japanese population: J-Kidney-Biobank. Journal of Human Genetics. 68(2). 55–64. 1 indexed citations
10.
Maki, Kenji, Jun Hata, Satoko Sakata, et al.. (2022). Serum Uric Acid Levels and Nephrosclerosis in a Population-Based Autopsy Study: The Hisayama Study. American Journal of Nephrology. 53(1). 69–77. 3 indexed citations
11.
12.
Hata, Jun, Tomomi Ide, Takuya Nagata, et al.. (2021). Urinary N-terminal pro–B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study. Environmental Health and Preventive Medicine. 26(1). 47–47. 2 indexed citations
13.
Fukui, Akiko, Masaru Nakayama, Shigeru Tanaka, et al.. (2020). Association between urinary salt excretion and albuminuria in Japanese patients with chronic kidney disease: the Fukuoka kidney disease registry study. Clinical and Experimental Nephrology. 25(1). 9–18. 1 indexed citations
14.
Tsuchimoto, Akihiro, Kenji Ueki, Yuta Matsukuma, et al.. (2020). Significance of revised criteria for chronic active T cell–mediated rejection in the 2017 Banff classification: Surveillance by 1-year protocol biopsies for kidney transplantation. American Journal of Transplantation. 21(1). 174–185. 13 indexed citations
15.
Nakano, Toshiaki, et al.. (2020). The glucose degradation product methylglyoxal induces immature angiogenesis in patients undergoing peritoneal dialysis. Biochemical and Biophysical Research Communications. 525(3). 767–772. 8 indexed citations
16.
Nagae, Hiroshi, et al.. (2020). The first case of COVID-19 pneumonia in a hemodialysis patient in Japan. CEN Case Reports. 9(4). 404–408. 6 indexed citations
17.
Yamada, Shunsuke, Masanori Tokumoto, Narihito Tatsumoto, et al.. (2014). Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia. American Journal of Physiology-Renal Physiology. 306(12). F1418–F1428. 142 indexed citations
18.
Nakano, Toshiaki & Hikaru Eto. (2011). Clinical and histopathological presentation of pustular psoriasis in an HLA-B27-positive Caucasian with reactive arthritis. 41(1). 97–102.
19.
Shikada, Yasunori, Yoshikazu Yonemitsu, Takaomi Koga, et al.. (2005). Platelet-Derived Growth Factor-AA Is an Essential and Autocrine Regulator of Vascular Endothelial Growth Factor Expression in Non–Small Cell Lung Carcinomas. Cancer Research. 65(16). 7241–7248. 87 indexed citations
20.
Hata, Shun-ichi, Yoshiyuki Ohsugi, Toshiaki Nakano, et al.. (1983). AN ANTI-OXIDATIVE AND IMMUNOMODULATING ACTIONS OF NEW ANTI-ARTHRITIC AGENT, CCA (LOBENZARIT DISODIUM). Journal of Pharmacobio-Dynamics. 6(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miho Shimizu Breakdown of academic impact, for papers by In Joo Kim Breakdown of academic impact, for papers by A. Testa Breakdown of academic impact, for papers by Yusuf Oğuz Breakdown of academic impact, for papers by Hui Huang Breakdown of academic impact, for papers by Jacob van den Born Breakdown of academic impact, for papers by Waichi Sato Breakdown of academic impact, for papers by Hyunjin Noh Breakdown of academic impact, for papers by Takeshi F. Andoh Breakdown of academic impact, for papers by Rui Zeng
Rankless by CCL
2026